Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver Metastases
Advanced Science · 2025
DOI: 10.1002/advs.202508040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Hengkai Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Liver Neoplasms, Pyridines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Youth Foundation of China, Fujian Province Finance Project, Joint Funds for the Innovation of Science and Technology of Fujian Province.
Abstract (Originalsprache)
Microsatellite stable colorectal cancer liver metastases (MSS‐CRLM) resist immune checkpoint inhibitors due to their immunosuppressive tumor microenvironment (TME) and low mutation burden (TMB). A personalized neoantigen vaccine, Neo‐CRCVAS, using whole‐exome and RNA sequencing of murine MSS‐CRC cells, comprising 7 immunogenic neoantigen peptides with Poly(I:C) is developed and combined with regorafenib as a novel therapy (RegoNeo). In MSS‐CRLM mouse models, RegoNeo significantly enhanced tumor regression and survival while establishing durable immune memory. Single‐cell RNA and TCR sequencing revealed that RegoNeo expanded a distinct Rgs2⁺CD8⁺ T cell population with strong cytotoxic activity and TCR clonal expansion. These Rgs2⁺CD8⁺ T cells, enriched for neoantigen‐specific T cells, demonstrated potent tumor‐killing capabilities in both mouse models and patient‐derived organoids. The findings establish RegoNeo as a promising personalized immunotherapy that reprograms the immunosuppressive tumor microenvironment by increasing Rgs2⁺CD8⁺ T cell infiltration, highlighting both the treatment approach and this specific T cell subset as potential therapeutic targets for MSS‐CRLM patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Department of Colorectal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
- Fujian Abdominal Surgery Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
ORCID-Profile: Hengkai Chen
Förderung
- National Natural Science Youth Foundation of China
- Fujian Province Finance Project
- Joint Funds for the Innovation of Science and Technology of Fujian Province
- Scientific Foundation of Fujian Province
- Young and Middle aged talent training project of Fujian provincial health commission
Zitieren
APA
Chen, H., Chen, B., Yang, Y., Li, S., Cai, H., Zhuang, Z., Wu, Y., Gao, Y., Chen, Y., Liu, X., Guan, G., & Zhuang, J. (2025). Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver Metastases. Advanced Science. https://doi.org/10.1002/advs.202508040
Vancouver
Chen H, Chen B, Yang Y, Li S, Cai H, Zhuang Z, et al. Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver Metastases. Advanced Science. 2025. doi:10.1002/advs.202508040
BibTeX
@article{Chen2025,
author = {Chen, Hengkai and Chen, Bin and Yang, Yuanfeng and Li, Shoufeng and Cai, Huajun and Zhuang, Zhicheng and Wu, Yong and Gao, Yuan and Chen, Yupeng and Liu, Xing and Guan, Guoxian and Zhuang, Jinfu},
title = {Personalized Neoantigen Vaccine plus Regorafenib Increases Rgs2⁺CD8⁺ T Cells Infiltration and Reprograms the Tumor Microenvironment in Microsatellite Stable Colorectal Cancer Liver Metastases},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202508040}
}
EUVIMED